Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg Other Refereed Contribution to Refereed Journals uri icon

Overview

Authors

  • Authorship

    • PROF John Zalcberg
    • JUDSON IR
    • VERWEIJ J
    • CASALI PG
    • LE CESNE A
    • REICHARDT P
    • BLAY JY
    • SCHLEMMER M
    • VAN GLABBEKE M
    • BROWN M

Published in

  • European Journal of Cancer

Time

Date/time value

  • 2005

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ejca.2005.04.034

Additional Document Info

Parent Title

  • EUROPEAN JOURNAL OF CANCER

Volume

  • 41

Issue

  • 12

Publisher

  • Pergamon-Elsevier Science